DOCSLIB.ORG

CHAPTER 3I ONYCHOMYCOSIS: There Is a Cure

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CHAPTER 3I ONYCHOMYCOSIS: There Is a Cure CHAPTER 3I ONYCHOMYCOSIS: There is a Cure Barbara S. Scblefman, D.P.M. Onychomycosis is the cause of 500/o of all nail 5. The immunosuppressed patient, where disturbances, with toenails being affected approxi- the body's ability to combat the infection mateiy 4 times as often as fingernails.' is compromised. Onychomycosis represents approximately one- 5. Postmenopausal women are affected, as third of all mycotic infections of the integument. estrogen appears to exerl a protective More than 48o/o of patients who are 70 years of age effect in younger women. Onychomycosis and oldeq and 320/o of 60 to 7}-year-old patients are seems to manifest itself in patients in their affected by the condition.'The overall incidence in 40s and 50s. the population is not known, but it is repofied to 'When comparing the stratum corneum of the be approximately 2 to 730/0.3 epidermis (skin) to the nail, one finds distinct The incidence of onychomycosis is on the rise keratins, with the presence of a high sulfur matrk today due to many factors. A growing proportion component in the nail plate. The fat content in nails of the population is elderly. \7ith the advent of is 0.1% to 70/o compared to 100/o in the stratum more advanced and broader antibiotics which kill corneum. The water content in nail is 70/o to 720/0, bacteria more effectively, fungi have proliferated. which is less than the corresponding value of 15- There is an increased use of antineopiastic 250/o for the stratum corneum. There no immunosuppressive drugs for organ transplants ^re sebaceous or eccrine glands in nails.T'B and AIDS patients. There is an increased propensity Onychomycosis is caused by dermatophytes for communal bathing places, recreational facilities, (90o/o), yeasts (60/o) and non-dermatophye molds health clubs etc., which provide an ideal setting for (4o/o).a Tinea unguium is ciinically defined as a fungal infections. In addition, occlusive footwear is dermatophyte infection of the nail plate. Of the more popular in the work place.' dermatophytes, Trichophl,ton tubtum (T. rubrum) Many factors will predispose a patient to is the offender in 900/o of the cases. Other dermato- onychomycosis. People in the following categories phytes causing onychomycosis include T. are more susceptible:5r' mentagrophltes, Microsporum gypseum or nanum, 7. Paiients with chronic Tinea pedis or and Epidermophyton floccosum or canis. Candida other foot infections. albicans accounts for 50-830/o of the Candida 2. Patients with advanced age who have species causing nail infections, although C. slower growth of the nail and decreased parapsilosis is emerging now as a main pathogen circulation. in various centers. Other species include C. lypoly- 3. Athletes where trauma to the nail weak- tica, C. fumata, and C. rugosa.e Yeasts are fungi that ens the seal between the nail plate and reproduce by budding.'0 Several non-dermatophye nail bed allowing fungal organisms to molds have been identified such as Scopulariopsis penetrate the nail unit. They also sweat brevicaulis, Aspergillus spp, Fusarium oxyspoftum, profusely. Runners are particularly prone Hendersonula toruloidea (Scytalidium dimidiatum), to onychomycosis. Scytalidium hyalinum, Acremonium tenuis, and 4. Exogenous heat/moisture which worsens Cephalosporium,3,'1 with Scopulariopsis and the condition as well as hyperhidrosis, as Scyalidium being the most prevalent. seen in anyone who wears shoes or Onychomycosis can be classified into 4 boots every day for 72 or more hours at different types: distal subungual onychomycosis, a time. People who wear sandals are less superficial white onychomycosis, proximal r,-r-rlnerable to fungi as their feet are subungual onychomycosis, and candidal ony- exposed to the air. chomycosis.10,1214 Distal Subungual Onychomycosis CHAPTER 31 l9l (DSO) is the most common variety and accounts There are several conditions that often mimic for 90o/o of onychomycosis. The disease begins with onychomycosis.6''3 Included in the differential an initial fungal penetration of the stratum corneum diagnosis are: from the hyponychial area, or from the lateral nail 1. Psoriasis, which causes a pitting of the fold. Characteristics include a yellow-brown nail plate surface in the fingernails as discoloration of the nail plate, onycholysis, and well as the toenails. subungual hyperkeratosis without thickening of the 2. Leukonychia, which is a white spot or actual nail plate. The predominant organism is T. band that appears proximally and grows rubrum. There may be a genetic predisposition out with the nail, which is usually caused with an autosomal dominant pattern. by trauma. These spots cannot be Superficial \7hite Onychomycosis (SVO) is burred-off as in S\WO. the second most common type, and occurs in 3. Lichen planus, which is an inflammatory approximately 1.0o/o of cases of onychomycosis. In skin disease that involves the nails in this type, fungi directly invade the nail plate and 70o/o of affected patients. Both hands and create a white crumbly appearance to the surface. feet have onychorrhexis (exaggerated The initial lesions may be randomly dispersed over longitudinal ridging) and "angel wing the nail, but with time these will eventually deformity" (the central portion of the nail coalesce to encompass the entire surface of the is raised, and the lateral poftion is nail. mentagrophyes predorninating T. is the depressed). organism. Treatment consists of mechanical 4. Yellow-nail syndrome is a condition that debridement as well as topical anti-fungals. The exists in conjunction with includes leukonychia, which Primary differential diagnosis lymphedema and chronic obstructive whitens the nail plate, but cannot be scraped off. pulmonary disease. It presents with an Proximal Subungual Onychomycosis (PSO) is absence of cuticles, yellow pigmentation, least common type and accounts for less the an excessive curve in the nall, with than 7o/o of onychomycosis. The infection pene- cessation of nail growth.'5 trates the proximal portion of the nail, resulting in hyperkeratosis and onycholysis. This type is usually Mycological testing includes the use of a associated with AIDS and is caused by T. rubrum. Potassium Hydroxide Slide Mount (KOH) as well as A recent study by Elewski et a1.'0 showed that a culture. The KOH technique involves applying 87.7o/o of 52 patients with AIDS had PSO. Non-HIV 150/o to 30% potassium hydroxide, either in water or infected patients typically have DSO. Presentations dimethyl sulfoxide, to the test media and viewing of PSO, especially in all ten fingernails should the results under a microscope. Heat can be increase one's suspicion of AIDS. Treatment with applied during preparation The incorporation of zidor,.r:dine for HIV is not affected during concomi- chlorazol black or Parkers blue/black ink, mixed in tant administration of itraconazole 3 equal volumes with KOH, will highlight nail fungi. Candidal Onychomycosis, primarily caused Phase contrast microscopy or dark field illumina- by Candida albicans, occurs in less than 70/o of tion will also highlight nail fungi.'6 onychomycosis and presents as three recognized Fungal cultures include the use of Sabouraud's forms. The first is a candidal paronychia that results and/or mycosel media. Dermatoph),te test medium in swelling and ery,thema of the proximal and (DTM) includes an antifung al/ antlbiotic cyclohex- lateral nail folds, with secondary involvement of imide that inhibits the growth of bacterial and the nail plate. The second is the typical distal and saprophltic fungi. It contains phenol red as a pH lateral onychomycosis (DSO) occurring when there indicator, and only dermatophl'tes will turn the test is separation of the nail plate from the nail bed medium from yellow to red." False positive and with erosion of the nail plate. The third is chronic negative results are coflunon. mucocutaneous candidiasis (CMC), where the Cultures require an adeqtate specimen. This organism directly invades the nail plate, and the involves clipping the full thickness nail together proximal and laleral nail folds become increasingly with debris from the underside of the na1l, and/or thick, until the nail becomes totally dystrophic. scraping the debris from the nail bed. In the case of SVO, one can scrape the surface of the nail. 192 CHAPTER 31 Some ffaditional antifungal agents used to treat true for itraconazole, with the pulse dosing being dermatophye infections include the following.5 superior over continuous therapy, and four pulses seems to have a slightly better result three. Azoles (ketoconazole, clotrimazoTe, than Doubling dose itraconazole from 100 to miconazole, sulconazole, oxiconazole, the of 200mg/day results in a 1O-fold increase in nail drug econazole),with or without urea. 1eve1s.35 Overall, terbinafine appears \Whitfield's ointment to be the drug dermatophyte Potassium permanganate of choice in the treatment of infections. Terbinafine can immuno- Ciclopirox Olamine be used in compromised patients, Amorolfine including those with AIDS, in the treatment of dermatophyosis. Increasing the Allylamines (naftifine, terbinafine) dose to will bring cure rates up to the Organic acids (saiicylic, undecylenic) 500m9/day Thiocarbamate derivatives (tolnaftate) level of those in otherwise healthy patients.'6 Itraconazole is more effective against Candida Polyenes (nystatin)-not effective against albicans some non-dermatoph),te dermatophyes and molds than terbinafine, and should be used where indicated At the present time there are five oral anti- based on culture
Load more

Recommended publications
  • Fungal Infections from Human and Animal Contact
    Journal of Patient-Centered Research and Reviews Volume 4 Issue 2 Article 4 4-25-2017 Fungal Infections From Human and Animal Contact Dennis J. Baumgardner Follow this and additional works at: https://aurora.org/jpcrr Part of the Bacterial Infections and Mycoses Commons, Infectious Disease Commons, and the Skin and Connective Tissue Diseases Commons Recommended Citation Baumgardner DJ. Fungal infections from human and animal contact. J Patient Cent Res Rev. 2017;4:78-89. doi: 10.17294/2330-0698.1418 Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes, and the patient experience. REVIEW Fungal Infections From Human and Animal Contact Dennis J. Baumgardner, MD Aurora University of Wisconsin Medical Group, Aurora Health Care, Milwaukee, WI; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI; Center for Urban Population Health, Milwaukee, WI Abstract Fungal infections in humans resulting from human or animal contact are relatively uncommon, but they include a significant proportion of dermatophyte infections. Some of the most commonly encountered diseases of the integument are dermatomycoses. Human or animal contact may be the source of all types of tinea infections, occasional candidal infections, and some other types of superficial or deep fungal infections. This narrative review focuses on the epidemiology, clinical features, diagnosis and treatment of anthropophilic dermatophyte infections primarily found in North America.
    [Show full text]
  • Antifungals, Topical
    Therapeutic Class Overview Antifungals, Topical INTRODUCTION The topical antifungals are available in multiple dosage forms and are indicated for a number of fungal infections and related conditions. In general, these agents are Food and Drug Administration (FDA)-approved for the treatment of cutaneous candidiasis, onychomycosis, seborrheic dermatitis, tinea corporis, tinea cruris, tinea pedis, and tinea versicolor (Clinical Pharmacology 2018). The antifungals may be further classified into the following categories based upon their chemical structures: allylamines (naftifine, terbinafine [only available over the counter (OTC)]), azoles (clotrimazole, econazole, efinaconazole, ketoconazole, luliconazole, miconazole, oxiconazole, sertaconazole, sulconazole), benzylamines (butenafine), hydroxypyridones (ciclopirox), oxaborole (tavaborole), polyenes (nystatin), thiocarbamates (tolnaftate [no FDA-approved formulations]), and miscellaneous (undecylenic acid [no FDA-approved formulations]) (Micromedex 2018). The topical antifungals are available as single entity and/or combination products. Two combination products, nystatin/triamcinolone and Lotrisone (clotrimazole/betamethasone), contain an antifungal and a corticosteroid preparation. The corticosteroid helps to decrease inflammation and indirectly hasten healing time. The other combination product, Vusion (miconazole/zinc oxide/white petrolatum), contains an antifungal and zinc oxide. Zinc oxide acts as a skin protectant and mild astringent with weak antiseptic properties and helps to
    [Show full text]
  • Onychomycosis/ (Suspected) Fungal Nail and Skin Protocol
    Onychomycosis/ (suspected) Fungal Nail and Skin Protocol Please check the boxes of the evaluation questions, actions and dispensing items you wish to include in your customized protocol. If additional or alternative products or services are provided, please include when making your selections. If you wish to include the condition description please also check the box. Description of Condition: Onychomycosis is a common nail condition. It is a fungal infection of the nail that differs from bacterial infections (often referred to as paronychia infections). It is very common for a patient to present with onychomycosis without a true paronychia infection. It is also very common for a patient with a paronychia infection to have secondary onychomycosis. Factors that can cause onychomycosis include: (1) environment: dark, closed, and damp like the conventional shoe, (2) trauma: blunt or repetitive, (3) heredity, (4) compromised immune system, (5) carbohydrate-rich diet, (6) vitamin deficiency or thyroid issues, (7) poor circulation or PVD, (8) poor-fitting shoe gear, (9) pedicures received in places with unsanitary conditions. Nails that are acute or in the early stages of infection may simply have some white spots or a white linear line. Chronic nail conditions may appear thickened, discolored, brittle or hardened (to the point that the patient is unable to trim the nails on their own). The nails may be painful to touch or with closed shoe gear or the nail condition may be purely cosmetic and not painful at all. *Ask patient to remove nail
    [Show full text]
  • Therapeutic Class Overview Antifungals, Topical
    Therapeutic Class Overview Antifungals, Topical INTRODUCTION The topical antifungals are available in multiple dosage forms and are indicated for a number of fungal infections and related conditions. In general, these agents are Food and Drug Administration (FDA)-approved for the treatment of cutaneous candidiasis, onychomycosis, seborrheic dermatitis, tinea corporis, tinea cruris, tinea pedis, and tinea versicolor (Clinical Pharmacology 2018). The antifungals may be further classified into the following categories based upon their chemical structures: allylamines (naftifine, terbinafine [only available over the counter (OTC)]), azoles (clotrimazole, econazole, efinaconazole, ketoconazole, luliconazole, miconazole, oxiconazole, sertaconazole, sulconazole), benzylamines (butenafine), hydroxypyridones (ciclopirox), oxaborole (tavaborole), polyenes (nystatin), thiocarbamates (tolnaftate [no FDA-approved formulations]), and miscellaneous (undecylenic acid [no FDA-approved formulations]) (Micromedex 2018). The topical antifungals are available as single entity and/or combination products. Two combination products, nystatin/triamcinolone and Lotrisone (clotrimazole/betamethasone), contain an antifungal and a corticosteroid preparation. The corticosteroid helps to decrease inflammation and indirectly hasten healing time. The other combination product, Vusion (miconazole/zinc oxide/white petrolatum), contains an antifungal and zinc oxide. Zinc oxide acts as a skin protectant and mild astringent with weak antiseptic properties and helps to
    [Show full text]
  • Below Chart Lists Over-The-Counter (OTC) Medicines Considered Low Risk for Pregnant Women When Taken for the Occasional Mild Illness
    Below chart lists over-the-counter (OTC) medicines considered low risk for pregnant women when taken for the occasional mild illness. It also mentions a few that are not safe. A few brand names are listed as examples, but there are many more on the market. Of course, nothing is 100 percent safe for all women, so it's a good idea to check with your doctor before taking any kind of medicine during pregnancy – even an over-the-counter product. Don't take more than the recommended dose and, if possible, avoid taking anything during your first trimester, when your developing baby is most vulnerable. NOTE: If you have a question about the safety of any medication during pregnancy, visit the Organization of Teratology Information Specialists Web site. There you'll find fact sheets on various drugs and exposures that can affect your baby as well as a list of teratogen information services that you can contact. Problem Safe to take Heartburn, gas and Antacids for heartburn (Maalox, Mylanta, Rolaids, Tums) bloating, upset stomach Simethicone for gas pains (Gas-X, Maalox Anti-Gas, Mylanta Gas, Mylicon) Cough or cold Guaifenesin, an expectorant (Hytuss, Mucinex, Naldecon Senior EX, Robitussin) Dextromethorphan, a cough suppressant (Benylin Adult, Robitussin Maximum Strength Cough, Scot-Tussin DM, Vicks 44 Cough Relief) Guaifenesin plus dextromethorphan (Benylin Expectorant, Robitussin DM, Vicks 44E) Cough drops Vicks VapoRub Not safe to take: Cold remedies that contain alcohol The decongestants pseudoephedrine and phenylephrine, which can affect blood
    [Show full text]
  • Ascosphaerales)
    INIII;ITION OFC1[ALKBROOD SPORE GERMINATIONIN VITRO (Ascosp haera aggrega ta: Ascosphaerales) Station Bulletin 656 January 1982 Agricultural Fxperiment Station Oreg' State University, Corvallis ¶ INHIBITION OF CHALKBROOD SPORE GERMINATION IN VITRO (Ascosphaera aggregata: Ascosphaerales.) W. P. Stephen, J.D. Vandenberg, B. L. Fichter, and G. Lahm Authors: Professor, research assistants and technician in theDepartment of Entomology, Oregon State University. ABSTRACT Sixty-five compounds, including general microbicides, fungicides, antibiotics, and fumigants were screened for their sporicidal effect on Ascosphaera aggregata. The chalkbrood spore, the only readily accessible stage of the fungus, was unaffected by most of the materials tested. Only the halogenated general microbicides, iodine, hypochiorite, and stabilized dry chlorine, demonstrated consistent sporicidal activity at low concen- trations. Suggestions are made as to possible disease control strategies. ACKNOWLEDGMENTS The Multistate Chalkbrood Project is supported by contributions from grower groups and industry representatives in Idaho, Nevada, Oregon, and Washington; the Idaho, Nevada, and Washington Alfalfa Seed Commissions; Universities of Idaho and Nevada-Reno; Oregon and Washington State Universities, and by a cooperative agreement with the USDA/SEA Federal Bee Laboratory, Logan, Utah. The authors thank Dr. J. Corner and Mr. D. McCutcheon, British Columbia Ministry of Agriculture and Food, Vernon and Surrey, B.C., for help with the ETO tests; Dr. G. Puritch, Canadian Forestry Service, Pacific Forest Research Center, Victoria, B.C., for supplying the fatty acid derivatives; and Dr. D. Coyier, IJSDA/SEA/AR Ornamental Plants Laboratory, Corvallis, Ore., for assistance with fumigation studies. 1 INTRODUCTION Ascosphaera aggregata Skou is the causative agent ofchalkbrood in larvae of the alfalfa leafcutting bee, Megachilerotundata (Fabricius) (Vandenberg and Stephen, 1982).
    [Show full text]
  • Dermatologic Nuances in Children with Skin of Color
    5/21/2019 Dermatologic Nuances in Children with Skin of Color Candrice R. Heath, MD, FAAP, FAAD Director, Pediatric Dermatology LKSOM Temple University @DrCandriceHeath Advisory Board – Pfizer, Regeneron-Sanofi Consultant –Marketing – Unilever, Proctor & Gamble Speaker’s Bureau - Pfizer I do not intend to discuss on-FDA approved or investigational use of products in my presentation. • Recognize common hair, scalp and skin disorders that may present differently in children with skin of color • Select appropriate treatment options based upon common cultural preferences to increase adherence • Establish treatment algorithm for challenging cases 1 5/21/2019 • 2050 : Over half of the United States population will be people of color • 2050 : 1 in 3 US residents will be Hispanic • 2023 : Over half of the children in the US will be people of color • Focuses on ethnic and racial groups who have – similar skin characteristics – similar skin diseases – similar reaction patterns to those skin diseases Taylor SC et al. (2016) Defining Skin of Color. In Taylor & Kelly’s Dermatology for Skin of Color. 2016 Type I always burns, never tans (palest) Type II usually burns, tans minimally Type III sometimes mild burn, tans uniformly Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown) Type VI Never burns (deeply pigmented dark brown to darkest brown) 2 5/21/2019 • Black • Asian • Hispanic • Other Not so fast… • Darker skin hues • The term “race” is faulty – Race may not equal biological or genetic inheritance – There is not one gene or characteristic that separates every person of one race from another Taylor SC et al.
    [Show full text]
  • Antifungal Drugs
    Antifungal Drugs Antifungal or antimycotic drugs are those agents used to treat diseases caused by fungus. Fungicides are drugs which destroy fungus and fungistatic drugs are those which prevent growth and multiplication of fungi. Collectively these drugs are often referred to as antimycotic or antifungal drugs. General characteristics of fungus: Fungi of medical significance are of two groups: Yeast Unicellular (Candida, Crytococcus) Molds Multicellular; filamentous consist of hyphae (Aspergillus, Microsporum, Trichophyton) They are eukaryotic i.e. they have well defined nucleus and other nuclear materials. They are made of thin threads called hyphae. The hyphae have a cell wall (like plant cells) made of a material called chitin. The hyphae are often multinucleate. They do not have chlorophyll, can’t make own food by photosynthesis, therefore derive nutrients by means of saprophytic or parasitic existence. Cell membrane is made up of ergosterol. Types of fungal infections: Fungal infections are termed as mycoses and in general can be divided into: Superficial infections: Affecting skin, nails, scalp or mucous membranes; e.g. Tinea versicolor Dermatophytosis: Fungi that affect keratin layer of skin, hair and nail; e.g. Tinea pedis, rign worm infection. Candidiasis: Yeast infections caused by (Malassezia pachydermatis), oral thrush (oral candidiasis), vulvo-vaginitis, nail infection. Systemic/Deep infections: Affecting deeper tissues and organ they usually affect lungs, heart and brain leading to pneumonia, endocarditis and meningitis. Systemic infections are associated with immunocompromised patients, these diseases are serious and often life threatening due to the organ involved. Some of the serious systemic fungal infections in man are candidiasis, cryptococcal meningitis, pulmonary aspergillosis.
    [Show full text]
  • Hair and Nail Disorders
    Hair and Nail Disorders E.J. Mayeaux, Jr., M.D., FAAFP Professor of Family Medicine Professor of Obstetrics/Gynecology Louisiana State University Health Sciences Center Shreveport, LA Hair Classification • Terminal (large) hairs – Found on the head and beard – Larger diameters and roots that extend into sub q fat LSUCourtesy Health of SciencesDr. E.J. Mayeaux, Center Jr., – M.D.USA Hair Classification • Vellus hairs are smaller in length and diameter and have less pigment • Intermediate hairs have mixed characteristics CourtesyLSU Health of E.J. Sciences Mayeaux, Jr.,Center M.D. – USA Life cycle of a hair • Hair grows at 0.35 mm/day • Cycle is typically as follows: – Anagen phase (active growth) - 3 years – Catagen (transitional) - 2-3 weeks – Telogen (preshedding or rest) about 3 Mon. • > 85% of hairs of the scalp are in Anagen – Lose 75 – 100 hairs a day • Each hair follicle’s cycle is usually asynchronous with others around it LSU Health Sciences Center – USA Alopecia Definition • Defined as partial or complete loss of hair from where it would normally grow • Can be total, diffuse, patchy, or localized Courtesy of E.J. Mayeaux, Jr., M.D. CourtesyLSU of Healththe Color Sciences Atlas of Family Center Medicine – USA Classification of Alopecia Scarring Nonscarring Neoplastic Medications Nevoid Congenital Injury such as burns Infectious Systemic illnesses Genetic (male pattern) (LE) Toxic (arsenic) Congenital Nutritional Traumatic Endocrine Immunologic PhysiologicLSU Health Sciences Center – USA General Evaluation of Hair Loss • Hx is
    [Show full text]
  • Nails: Tales, Fails and What Prevails in Treating Onychomycosis
    J. Hibler, D.O. OhioHealth - O’Bleness Memorial Hospital, Athens, Ohio AOCD Annual Conference Orlando, Florida 10.18.15 A) Onychodystrophy B) Onychogryphosis C)“Question Onychomycosis dogma” – Michael Conroy, MD D) All the above E) None of the above Nail development begins at 8-10 weeks EGA Complete by 5th month Keratinization ~11 weeks No granular layer Nail plate growth: Fingernails 3 mm/month, toenails 1 mm/month Faster in summer or winter? Summer! Index finger or 5th digit nail grows faster? Index finger! Faster growth to middle or lateral edge of each nail? Lateral! Elkonyxis Mee’s lines Aka leukonychia striata Arsenic poisoning Trauma Medications Illness Psoriasis flare Muerhrcke’s bands Hypoalbuminemia Chemotherapy Half & half nails Aka Lindsay’s nails Chronic renal disease Terry’s nails Liver failure, Cirrhosis Malnutrition Diabetes Cardiovascular disease True or False: Onychomycosis = Tinea Unguium? FALSE. Onychomycosis: A fungal disease of the nails (all causes) Dermatophytes, yeasts, molds Tinea unguium: A fungal disease of nail caused by dermatophyte fungi Onychodystrophy ≠ onychomycosis Accounts for up to 50% of all nail disorders Prevalence; 14-28% of > 60 year-olds Variety of subtypes; know them! Sequelae What is the most common cause of onychomycosis? A) Epidermophyton floccosum B) Microsporum spp C) Trichophyton mentagrophytes D) Trichophyton rubrum -Account for ~90% of infections Dermatophytes Trichophyton rubrum Trichophyton mentagrophytes Trichophyton tonsurans, Microsporum canis, Epidermophyton floccosum Nondermatophyte molds Acremonium spp, Fusarium spp Scopulariopsis spp, Sytalidium spp, Aspergillus spp Yeast Candida parapsilosis Candida albicans Candida spp Distal/lateral subungal Proximal subungual onychomycosis onychomycosis (DLSO) (PSO) Most common; T. rubrum Often in immunosuppressed patients T.
    [Show full text]
  • Preserving the Faith a Cosmetic Formulators Overview John Woodruff John Woodruff: the Personal Stuff
    Preserving the faith A cosmetic formulators overview John Woodruff www.creative-developments.co.uk John Woodruff: the personal stuff 1960: joined Smith & Nephew Research 1976: Co-founded Pava, responsible for all technical aspects, from formulation and development to manufacture and filling and originated many well-known brands. October 1988: Established consulting laboratory for formulation of cosmetics and toiletry products. Developed Creativity a unique programme written for formula creation and cosmetic manufacture Two books and many articles published on cosmetic technology. Twice appeared as an expert witness, 3 times Chairman of the European UV & Sun Filters Conference, Twice chaired a technical session at In-Cosmetics 1990 – 1996: Cosmetics Consultant to Manufacturing Chemist 1996 – Present: Regular contributions to Soap, Perfumery and Cosmetics (SPC) Supports the Distance Leaning Course run by the SCS Lectures on product formulation at the Principles and Practice of Cosmetic Science When he is not working he is sailing. 2 The cosmetic product brief • Product type • Claims • Product format • Application • Texture • Colour • Perfume • Packaging • Cost 3 What about the preservative? Preservatives are one of the last things that most chemists think about when formulating a product and one of the first things that are suspected when a problem occurs. They are important ingredients, the value of which is never noticed when functioning properly and which are worthless when not. Preservatives are much maligned and misunderstood within the cosmetics industry. Because of this, they are often over-dosed, under-dosed or improperly formulated even by experienced chemists Cosmetic formulations require a delicate balance of a large number of raw materials.
    [Show full text]
  • Trachyonychia Associated with Alopecia Areata and Secondary Onychomycosis
    TRACHYONYCHIA ASSOCIATED WITH ALOPECIA AREATA AND SECONDARY ONYCHOMYCOSIS Jose L. Anggowarsito Renate T. Kandou Department of Dermatovenereology Medical Faculty of Sam Ratulangi University Prof. Dr. R. D. Kandou Hospital Manado Email: [email protected] Abstract: Trachyonychia is an idiopathic nail inflammatory disorder that causes nail matrix keratinization abnormality, often found in children, and associated with alopecia areata, psoriasis, atopic dermatitis, or nail lichen planus. Trachyonychia could be a manifestation of associated pleomorphic or idiopathic disorders; therefore, it may occur without skin or other systemic disorders. There is no specific diagnostic criteria for tracyonychia. A biopsy is needed to determine the definite pathologic diagnosis for nail matrix disorder; albeit, in a trachyonychia case it is not entirely necessary. Trachyonychia assessment is often unsatisfactory and its management is focused primarily on the underlying disease. We reported an 8-year-old girl with twenty dystrophic nails associated with alopecia areata. Cultures of nail base scrapings were performed two times and the final impression was trichophyton rubrum. Conclusion: Based on the clinical examination and all the tests performed the diagnosis of this case was trachyonychia with twenty dystrophic nails associated with alopecia areata and secondary onychomycosis.The majority of trachyonychia cases undergo spontaneous improvement; therefore, a specific therapy seems unnecessary. Onychomycosis is often difficult to be treated. Eradication of the fungi is not always followed by nail restructure, especially if there has been dystrophy before the infection. Keywords: trachyonychia, alopecia areata, onychomycosis. Abstrak: Trakionikia adalah inflamasi kuku idiopatik yang menyebabkan gangguan keratinisasi matriks kuku, sering terjadi pada anak, dan terkait dengan alopesia areata, psoriasis, dermatitis atopik atau lichen planus kuku.
    [Show full text]